‘action needed to counter bioterrorism’


Play all audios:

Access through your institution Buy or subscribe WASHINGTON The United States is failing to employ the power of its biotechnology and pharmaceutical industries to counter a growing threat


from biological terrorism, an expert conference was told last week. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution


Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full


article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs *


Contact customer support Authors * Meredith Wadman View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT


THIS ARTICLE CITE THIS ARTICLE Wadman, M. ‘Action needed to counter bioterrorism’. _Nature_ 388, 703 (1997). https://doi.org/10.1038/41839 Download citation * Issue Date: 21 August 1997 *


DOI: https://doi.org/10.1038/41839 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently


available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative